circulating tumor cells in prostate cancer - the premise and the promise
Published 9 years ago • 1.3K plays • Length 30:17Download video MP4
Download video MP3
Similar videos
-
13:01
prostate cancer: progress and promise, part iii - panel discussion
-
14:53
prostate cancer: progress and promise part v – panel discussion
-
32:47
prostate cancer biomarkers in context
-
0:33
circulating tumor cells in management of patients with castration-resistant prostate cancer
-
30:32
progress and challenges towards the personalized treatment of prostate cancer
-
6:13
analysis of circulating prostate cancer tumor cells
-
1:30
how far away are we from implementing ctc-based approaches in prostate cancer?
-
1:32:29
candid conversations on modern urothelial cancer management
-
30:26
the genomic architecture of prostate cancer
-
0:46
ctc hoxb13 rna in mcrpc: abiraterone/enzalutamide impact
-
22:11
is prostate cancer responsive to the immune system?
-
1:25
potential of ctcs for biomarker detection in prostate cancer
-
22:16
bone-targeted therapy for prostate cancer
-
0:39
stereotactic body rt in patients with oligometastatic crpc undergoing 1l treatment with abiraterone
-
34:46
prostate cancer: progress and promise - september, 2011: roundtable discussion
-
23:57
inflammatory chemokines in prostate cancer: where, what and when to target?
-
2:18
practical recommendations for circulating tumor cells in prostate cancer
-
1:12
dr. scher on the future of the circulating tumor cell test
-
0:31
unmet needs in the use of circulating tumor cells for prostate cancer